Sana Kagermazova

Sana Kagermazova has extensive experience in the pharmaceutical and biomedical sectors, currently working at DM RWE since September 2022, focusing on Real World Data and Real World Evidence studies. Previously, Kagermazova served as Post Market Safety Surveillance Manager for AbbVie and Allergan in the CIS and Ukraine regions, implementing comprehensive safety surveillance systems and managing pharmacovigilance processes. At Skolkovo Foundation, projects involved scouting innovative biomedical startups and securing governmental partnerships. Early career highlights include roles at Bristol-Myers Squibb managing post-market pharmacovigilance and conducting market research at MRC Pharmexpert. Kagermazova holds a Doctor of Pharmacy degree specializing in Pharmaceutical Marketing and Management from Peoples’ Friendship University of Russia.